Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC

Ankit Dhiman; Emily Fenton; Jeffrey Whitridge; Jennifer Belanski; Whitney Petersen; Sarah Macaraeg; Govind Rangrass; Ardaman Shergill; Dejan Micic; Oliver S Eng; Kiran Turaga

doi:10.1245/s10434-021-09973-1

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC

Ann Surg Oncol. 2021 Nov;28(12):6955-6964. doi: 10.1245/s10434-021-09973-1. Epub 2021 May 5.

Authors

Affiliations

¹ Department of Surgery, University of Chicago, 5841 S. Maryland Ave, MC 5094, Chicago, IL, 60637, USA.
² University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
³ Department of Anesthesiology, University of Chicago, Chicago, IL, USA.
⁴ Department of Medicine, University of Chicago, Chicago, IL, USA.
⁵ Department of Surgery, University of Chicago, 5841 S. Maryland Ave, MC 5094, Chicago, IL, 60637, USA. kturaga@surgery.bsd.uchicago.edu.

PMID: 33954868
DOI: 10.1245/s10434-021-09973-1

Abstract

ERAS protocols may reduce length of stay and return to full functional recovery after cytoreductive surgery and HIPEC. Prehabilitation programs and post-operative goal directed pathways, along with other essential components of ERAS are discussed with supporting evidence.

MeSH terms

Cytoreduction Surgical Procedures
Enhanced Recovery After Surgery*
Humans
Hyperthermic Intraperitoneal Chemotherapy
Length of Stay
Neoplasms* / surgery
Postoperative Complications
Postoperative Period